Sure, there are a lot of transcatheter valves around, each with strengths and weaknesses. But if the trials show that this valve is easy to position, stays in place, is durable and has haemodynamic performance that is as good or better than the competition then it has the potential to become the market leader.
Anteris Channel 9 Interview 2022, page-32
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.80 |
Change
-0.400(2.08%) |
Mkt cap ! $370.7M | |||
| Open | High | Low | Value | Volume |
| $19.10 | $19.45 | $18.80 | $145.3K | 7.63K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 540 | $18.75 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.99 | 313 | 1 |
View Market Depth
| Last trade - 11.08am 29/05/2024 (20 minute delay) ? |
| AVR (ASX) Chart |